The United States and Zambia signed a $2.49 billion health financing agreement in Lusaka on Thursday, after Washington backed down on two of its most controversial demands: access to patient specimens and data, and a linkage to Zambia's critical minerals.
Under the five-year pact, the U.S. contributes $1.52 billion and Zambia invests $975 million, according to the U.S. State Department. Zambian officials have publicly cited a different figure — $1.5 billion from the U.S. plus $2.1 billion from Zambia, for a $3.6 billion total — so the final accounting is still disputed even as the deal is signed.
What Washington Gave Up
Two clauses that had stalled the negotiations for months were removed completely before signing:
- The specimen-sharing clause, which would have required Zambia to send patient biological specimens to U.S. authorities on request. "The Government will not be sharing any specimens with the United States," Health Minister Roma Chilengi said.
- Broad data-sharing provisions. Remaining data sharing is now limited to information needed to monitor and evaluate U.S.-funded health programs.
Critically, the deal contains no clauses linked to mineral resources. Earlier, the U.S. had tried tying health funding to preferential American access to Zambia's copper and other critical minerals. That coupling was set aside after bilateral talks on the sidelines of the 81st UN General Assembly in New York, where Zambia's Foreign Affairs Minister Mulambo Haimbe met U.S. Deputy Assistant Secretary of State Chris Kulukundis. Chilengi said there is "no mention of critical minerals" in the pact and that he is not aware of a separate minerals agreement being negotiated.
Lusaka had rejected an initial five-year, $2 billion U.S. aid package earlier this year over unrestricted pathogen-tracking data access and the minerals linkage — and this week got both dropped.
What the Money Funds
The agreement covers HIV/AIDS, malaria and tuberculosis programs, laboratory diagnostic networks, health-tracking information systems, and medical staffing. The U.S. says the deal will fund the recruitment of 40,000 healthcare workers over five years; Zambia also plans to bring 25,000 community health workers into the formal system, with full procurement integration under the national drug agency ZAMMSA. The target: all 10 provinces and 116 districts, running 2026–2030.
The pact is part of the Trump administration's "America First Global Health Strategy," built around co-financing memoranda with African nations after USAID was dismantled — a model in which African governments gradually raise their own health spending while U.S. assistance phases out.
A Wider African Tug-of-War
Zambia's win lands in a continent-wide fight over the new-style deals. The U.S. has signed similar health data and specimen-sharing agreements with at least nine African nations, committing them to send data and specimens within five days of a request, with Washington able to pass them to up to 10 American non-government entities for diagnostics and treatments. Kenya, Tanzania and Uganda signed; Ghana, Zimbabwe and Namibia rejected the deals over data-sharing concerns.
The backdrop in Zambia was rocky: in 2025 the U.S. withdrew $50 million in annual health aid over "systemic theft" of donated medicines, and in the week before signing, Zambia's government fired all 150 workers at ZAMMSA, the drug-distribution agency. The new MoU itself is not being made public, and as a memorandum it does not require parliamentary approval — the Cabinet approved it.
Why It Matters
Zambia just demonstrated that African governments can negotiate down the new Washington — dropping specimen transfers, narrowing data access, and delinking minerals from medicine entirely. Whether the disputed dollar figures and the undisclosed MoU text hold up under scrutiny will determine if this "historic co-financing landmark," as Chilengi called it, becomes a template or a cautionary tale.
Watch: Firstpost Africa — "How Zambia Forced Trump Administration to Back Down in US Health Deal Talks," a four-minute explainer on the revised five-year agreement, the stalled demands over patient records and biological samples, and how the redrafted terms protect patient privacy and mineral assets.
Music in this post's reel: Kevin MacLeod - Long Road Ahead (incompetech.com), licensed under CC BY 3.0
Sources: The Associated Press, Reuters, Lusaka Times, Open Zambia